Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study-Reference-Cited by-同舟云学术

Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study

Published:2023-11-11 Issue: Volume: Page:
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Giladi Odil^ORCID,Bagnato Gianmarco,Gentilini Marianna,Shimony Shai,Pasvolsky Oren,Berger Tamar,Itchaki Gilad,Raanani Pia,Lolli Ginerva,Stefoni Vittorio,Broccoli Alessandro,Argnani Lisa,Zinzani Pier Luigi,Gurion Ronit

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05543-5.pdf

Reference25 articles.

1. Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66(6):443–459

2. Lee S, Fujita K, Negoro E, Morishita T, Yamauchi H, Oiwa K et al (2019) The impact of diagnostic wait time on the survival of patients with diffuse large B-cell Lymphoma: effect modification by the International Prognostic Index. Br J Haematol 187(2):195–205

3. Gutierrez A, Bautista-Gili AM, Bento L, Herraez I, Garcia L, Martinez-serra J et al (2013) Impact of dose-density delays in diffuse large B-Cell Lymphoma (DLBCL) treated with R-CHOP21 or R-CHOP14. Blood 122(21):4374–4374

4. Shah V, Ko Ko T, Zuckerman M, Vidler J, Sharif S, Mehra V et al (2020) Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience. Br J Haematol 190(5):e279–e282

5. Duléry R, Lamure S, Delord M, Di Blasi R, Chauchet A, Hueso T et al (2021) Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-hodgkin Lymphoma treated with B-cell depleting immunotherapy. Am J Hematol 96(8):934–944

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DLD is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients;Apoptosis;2024-04-06

2. The Possible Role of Pathogens and Chronic Immune Stimulation in the Development of Diffuse Large B-Cell Lymphoma;Biomedicines;2024-03-14